PEMF healing technology is reported to reduce healing time for uncomplicated human bone fractures to about 2-4 weeks, and to accelerate recovery time for knee/hip replacements. These reports are consistent with FDA approved application of this technology for non-union bone fractures. Healing of non-union fractures is physiologically consistent to accelerated healing for normal fractures.
We are sponsoring two orthopedic recovery confirmation cases. Participant requirements:
Have scheduled an active qualifying condtion, hip replacement, knee replacement, or have a recently fractured tibia, fibia or femur;
Ability to supply digital medical images at two week intervals, before/during/after;
Grant permission to use and reproduce the digital medical images;
Sign an informed consent for use of experimental technology;
This is not an FDA-clinical trial. This is preliminary case study to determine if observed results are reproducible. The technologies we use are non-invasive, and have been in use for 20 years. They are approved for non-union joint fractures, but are not approved to accelerate healing of normal trauma.
For non-trial participants, the cost of applying this approach is $10K for one month. If your recovery is not accelerated to less than 4 weeks, we reduce charges to $2K. We limit the charge reduction offer to the US. This method is experimental. It is not covered by insurance.
This approach overlays standard care, and can be applied after casting, or in conjunction with CPM. Preliminary results show over 80% reduction in pain and discomfort. In most cases a significant reduction in pain management is required.
PEMF overlays cast or splint;
Oral phospholipids to accelerate cellular regeneration;